Evidence map›Paper›PMID 31966426›Full record

ArticleInternational journal of clinical and experimental pathology2017

Accelerated development of instability-induced osteoarthritis in transgenic mice overexpressing SOST.

Sheng Zhou, Yuxiang Ge, Yixuan Li, Zhengyuan Bao, Chen Yao, Huajian Teng, Qing Jiang

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 65% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. WNT Signalling in Osteoarthritis and Its Pharmacological Targeting.Handbook of experimental pharmacology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Sheng ZhouDepartment of Sports Medicine and Adult Reconstructive Surgery, Drum Tower Hospital, School of Medicine, Nanjing University Nanjing, Jiangsu, China.
Yuxiang GeDepartment of Sports Medicine and Adult Reconstructive Surgery, Drum Tower Hospital, School of Medicine, Nanjing University Nanjing, Jiangsu, China.
Yixuan LiDepartment of Sports Medicine and Adult Reconstructive Surgery, Drum Tower Hospital, School of Medicine, Nanjing University Nanjing, Jiangsu, China.
Zhengyuan BaoDepartment of Sports Medicine and Adult Reconstructive Surgery, Drum Tower of Clinical Medicine, Nanjing Medical University Nanjing, China.
Chen YaoDepartment of Sports Medicine and Adult Reconstructive Surgery, Drum Tower of Clinical Medicine, Nanjing Medical University Nanjing, China.
Huajian TengLaboratory for Bone and Joint Disease, Model Animal Research Center (MARC), Nanjing University Nanjing, Jiangsu, China.
Qing JiangDepartment of Sports Medicine and Adult Reconstructive Surgery, Drum Tower Hospital, School of Medicine, Nanjing University Nanjing, Jiangsu, China.
Nanjing Drum Tower Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveSclerostin (SOST), acting as a Wnt antagonist, has been shown to play a key role in regulating bone homestasis, and has also been linked to osteoarthritis (OA) development. Here, we investigated whether overexpressing SOST could affect OA development after destabilization of the medial meniscus (DMM) using

methodsBone and cartilage phenotypes of

resultsTen-week-old

conclusionOverexpressing SOST led to accelerated development of instability-induced OA. Our data further highlight that cartilage homeostasis requires finely tuned Wnt signaling.

Indexed as

cartilageosteoarthritisSclerostinsubchondral bone

Identifiers

PMID31966426
PMCPMC6965855
OpenAlexW3027338798

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.